Target Healthcare Reit Stock Current Valuation
| THRL Stock | 92.30 1.00 1.07% |
Valuation analysis of Target Healthcare REIT helps investors to measure Target Healthcare's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Target Healthcare's Cash is comparatively stable compared to the past year. Change In Cash is likely to gain to about 22.2 M in 2025, whereas Free Cash Flow is likely to drop slightly above 27.3 M in 2025. Fundamental drivers impacting Target Healthcare's valuation include:
Price Book 0.8261 | Enterprise Value 786.7 M | Enterprise Value Ebitda 26.253 | Price Sales 7.4511 | Forward PE 14.8148 |
Undervalued
Today
Please note that Target Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Target Healthcare REIT is based on 3 months time horizon. Increasing Target Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Target stock is determined by what a typical buyer is willing to pay for full or partial control of Target Healthcare REIT. Since Target Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Target Stock. However, Target Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 92.3 | Real 106.52 | Hype 93.49 | Naive 96.69 |
The intrinsic value of Target Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Target Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Target Healthcare REIT helps investors to forecast how Target stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Target Healthcare more accurately as focusing exclusively on Target Healthcare's fundamentals will not take into account other important factors: Target Healthcare REIT Company Current Valuation Analysis
Target Healthcare's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Target Healthcare Current Valuation | 786.75 M |
Most of Target Healthcare's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Target Healthcare REIT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Target Healthcare REIT has a Current Valuation of 786.75 M. This is 94.81% lower than that of the Diversified REITs sector and significantly higher than that of the Real Estate industry. The current valuation for all United Kingdom stocks is 95.27% higher than that of the company.
Target Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Target Healthcare's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Target Healthcare could also be used in its relative valuation, which is a method of valuing Target Healthcare by comparing valuation metrics of similar companies.Target Healthcare is currently under evaluation in current valuation category among its peers.
Target Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0383 | ||||
| Profit Margin | 1.02 % | ||||
| Operating Margin | 0.84 % | ||||
| Current Valuation | 786.75 M | ||||
| Shares Outstanding | 620.24 M | ||||
| Shares Owned By Insiders | 0.07 % | ||||
| Shares Owned By Institutions | 66.95 % | ||||
| Price To Book | 0.83 X | ||||
| Price To Sales | 7.45 X | ||||
| Revenue | 69.55 M | ||||
| Gross Profit | 63.01 M | ||||
| EBITDA | 58 M | ||||
| Net Income | 73.02 M | ||||
| Total Debt | 240.67 M | ||||
| Book Value Per Share | 1.13 X | ||||
| Cash Flow From Operations | 42.34 M | ||||
| Earnings Per Share | 0.12 X | ||||
| Target Price | 95.0 | ||||
| Beta | 0.45 | ||||
| Market Capitalization | 581.78 M | ||||
| Total Asset | 967.37 M | ||||
| Retained Earnings | 176.7 M | ||||
| Annual Yield | 0.06 % | ||||
| Net Asset | 967.37 M | ||||
| Last Dividend Paid | 0.058 |
About Target Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Target Healthcare REIT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Target Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Target Healthcare REIT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Target Stock Analysis
When running Target Healthcare's price analysis, check to measure Target Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Target Healthcare is operating at the current time. Most of Target Healthcare's value examination focuses on studying past and present price action to predict the probability of Target Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Target Healthcare's price. Additionally, you may evaluate how the addition of Target Healthcare to your portfolios can decrease your overall portfolio volatility.